Equitable Trust CO Charles River Laboratories International, Inc. Transaction History
Equitable Trust CO
- $1.47 Billion
- Q3 2024
A detailed history of Equitable Trust CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Equitable Trust CO holds 2,423 shares of CRL stock, worth $479,148. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,423
Previous 2,466
1.74%
Holding current value
$479,148
Previous $509,000
6.29%
% of portfolio
0.03%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
698Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$740 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$421 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$384 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...